|
Market Closed -
Nasdaq
23:30:00 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.880 USD | -3.37% |
|
+15.64% | -11.27% |
| 10-26 | Adial Pharmaceuticals, Inc. Announces CFO Changes | CI |
| 10-16 | Adial Pharmaceuticals, Inc. Announces Appointment of David Rubenstein, M.D., Ph.D. as Chief Scientist | CI |
| Market Cap | 13.26M 11.88M 10.96M 9.92M 18.54M 1.26B 18.84M 131M 52.15M 661M 49.77M 48.71M 2.09B | P/E 2026 * |
-3.34x | P/E 2027 * | -8.28x |
|---|---|---|---|---|---|
| Enterprise Value | 13.26M 11.88M 10.96M 9.92M 18.54M 1.26B 18.84M 131M 52.15M 661M 49.77M 48.71M 2.09B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
92.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADIL | Delayed | |
CBOE
| ADIL | Real-time |
Last Transcript: Adial Pharmaceuticals, Inc.
| 08/03/23 | Wall Street kleurt rood door Powell | |
| 07/03/23 | Havikige Powell duwt Wall Street in het rood | |
| 07/03/23 | Wall Street wacht op Powell |
| 1 day | -3.37% | ||
| 1 week | +15.64% | ||
| Current month | +21.70% | ||
| 1 month | +17.59% | ||
| 3 months | +54.92% | ||
| 6 months | +214.84% | ||
| Current year | -11.27% |
| 1 week | 3.59 |  | 5.15 |
| 1 month | 3 | | 5.15 |
| Current year | 1.31 | | 7.2 |
| 1 year | 1.31 | | 9.22 |
| 3 years | 1.31 | | 104.25 |
| 5 years | 1.31 | | 2,200 |
| 10 years | 1.31 | | 5,900 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/17/26 A | Free | Director | 25,666 | 0.9774% | ||
| 4/7/26 A | Free | Chief Financial Officer | 17,325 | 1.2133% | ||
| 4/7/26 A | Free | Chairman | 9,185 | 0.6432% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.37% | +15.64% | -44.26% | -89.99% | 13.26M | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.26% | +12.91% | +82.98% | 55.53B | |
| +1.75% | +2.76% | +12.38% | +103.69% | 53.03B | |
| -1.43% | -0.57% | +26.10% | +52.86% | 45.99B | |
| -0.48% | -3.86% | +17.27% | +117.99% | 42.45B | |
| +0.82% | -2.06% | +227.09% | +922.41% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +44.58% | +102.84% | +88.74% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.67% | +5.73% | +42.52% | +137.93% | 39.26B | |
| Weighted average by Cap. | -0.11% | +3.13% | +49.26% | +160.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -65.46M -58.63M -54.09M -48.95M -91.53M -6.23B -93.01M -645M -257M -3.26B -246M -240M -10.33B | -21.14M -18.93M -17.47M -15.81M -29.56M -2.01B -30.03M -208M -83.13M -1.05B -79.33M -77.64M -3.34B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $4.880 | -3.37% | 146,852 |
| 28/10/26 | $5.050 | +36.12% | 99,654 |
| 27/10/26 | $3.710 | +0.82% | 7,357 |
| 26/10/26 | $3.680 | -6.12% | 11,696 |
| 23/10/26 | $3.920 | -7.11% | 47,359 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADIL Stock
Select your edition
All financial news and data tailored to specific country editions
